96991 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Products of obesity genes, e.g. leptin, obese (OB), tub, fat
METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY
#2MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
#3Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
#4Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
#5GENETICALLY-MODIFIED SACCHAROMYCES YEAST STRAINS AS PREVENTATIVE AND THERAPEUTIC AGENTS
#6Pancreatic Islets as Protein Factories
#7PEPTIDE USED FOR IMMUNOTHERAPEUTICS
#8COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF
#9METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#10Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
#11METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#12METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#13METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#14METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#15METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#16METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#17Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin
#18NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA
#19ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
#20METHODS FOR ENRICHING MARROW INFILTRATING LYMPHOCYTES ("MILS"), COMPOSITIONS CONTAINING ENRICHED MILS, AND METHODS OF USING ENRICHED MILS
#21ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS
#22FUSOKINES INVOLVING CYTOKINES WITH STRONGLY REDUCED RECEPTOR BINDING AFFINITIES
#23ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS
#24METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY
#25CHIMERIC ACTIVATORS: QUANTITATIVELY DESIGNED PROTEIN THERAPEUTICS AND USES THEREOF
#26Leptin immunogens, hybridoma cells, monoclonal antibodies, polyclonal antibodies and use thereof
#27MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
#28COMPOUNDS, COMPOSITIONS, METHODS, AND USES FOR TREATING LEPTIN RESISTANCE, OBESITY, DIABETES MELLITUS AND METABOLIC SYNDROME
#29Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes
#30Adiponectin peptidomimetics for treating ocular disorders
#31Engineered polypeptides having enhanced duration of action
#32Expression of metabolic modulators in tumor microenvironment to improve tumor therapy
#33Coiled coil immunoglobulin fusion proteins and compositions thereof
#34LEPTIN PEPTIDES AND THEIR USE FOR TREATING NEUROLOGICAL DISORDERS
#35Combinatorial gene construct and non-viral delivery for anti-obesity
#36Therapeutic targeting of SET1B/compass pathway for treating cancers
#373′ end caps, 5′ end caps and combinations thereof for therapeutic RNA
#38Adiponectin peptidomimetics for treating ocular disorders
#39Peptide having anti-obesity and anti-diabetes efficacy and use thereof
#40METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#41Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin
#42KLK6-MEDIATED CNS-SPECIFIC ANTIBODY PRODRUG ACTIVATION
#43FUSION POLYPEPTIDE COMPRISING THE EXTRACELLULAR BINDING DOMAIN OF GROWTH HORMONE RECEPTOR
#44Fusokines involving cytokines with strongly reduced receptor binding affinities
#45Nucleic acids encoding repetitive amino acid sequences rich in proline and alanine residues that have low repetitive nucleotide sequences
#46MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
#47Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
#48Methods and compositions related to functional polypeptides embedded in heterologous protein scaffolds
#49Polypeptides capable of inhibiting the binding between leptin and Neuropilin-1
#50Adiponectin peptidomimetics for treating ocular disorders
#51Fusokines involving cytokines with strongly reduced receptor binding affinities
#52Compilation of detection reagents, in-vitro method for detecting mutated leptin, and use of a detection reagent
#53Adiponectin peptidomimetics for treating ocular disorders
#54Leptin active peptide having cd loop and E helix region mutations, coding gene thereof, and application thereof
#55Leptin active peptide having D helix region mutations, coding gene thereof, and application thereof
#56Therapeutic targeting of SET1B/compass pathway for treating cancers
#57Fusion Protein Comprising Leptin and Methods for Producing and Using the Same
#583′ end caps, 5′ end caps and combinations thereof for therapeutic RNA
#59Method of highly expressing target protein from plant using RbcS fusion protein and method of preparing composition for oral administration of medical protein using target protein expression plant body
#60CHIMERIC ACTIVATORS: QUANTITATIVELY DESIGNED PROTEIN THERAPEUTICS AND USES THEREOF
#61Anti-obesity compounds derived from neuromedin U
#62PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF
#63Composition comprising peptide derived from adiponectin
#64Engineered polypeptides having enhanced duration of action and reduced immunogenicity
#65Coiled coil immunoglobulin fusion proteins and compositions thereof
#66ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
#67Chimeric leptin polypeptide and method of using the same
#68Bovine fusion antibodies
#69Method of treating obesity in a companion animal comprising administering a modified canine leptin polypeptide
#70Albumin fusion proteins
#71Albumin fusion proteins
#72ENGINEERED POYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUCED IMMUNOGENICITY
#73Engineered bacteria for oral delivery of glucoregulatory proteins
#74Bovine fusion antibodies
#75Suppression of prostate cancer using a targeted clostridial neurotoxin
#76CTRP6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
#77Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
#78Adiponectin receptor agonists and methods of use
#79LEPTIN DERIVATIVES
#80ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
#81High affinity leptins and leptin antagonists
#82COMPOSITIONS AND METHODS FOR THE TRANSPORT OF THERAPEUTIC AGENTS
#83Modified leptin polypeptides and their uses
#84Leptin antagonist and methods of use
#85Adiponectin-containing eating behavior control agent for oral administration
#86Leptin agonist and methods of use
#87Albumin fusion proteins
#88PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF
#89LEPTIN AND LEPTIN ANALOG CONJUGATES AND USES THEREOF
#90Chimeric activators: quantitatively designed protein therapeutics and uses thereof
#91Methods for decreasing leptin levels or activity for treating inflammation
#92BL21 strain lacking a functional group II capsular gene cluster
#93Nucleic acids encoding modulators of body weight
#94Leptin peptide antagonists
#95Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
#96Isolated antibodies against biologically active leptin-related peptides
#97LEPTIN FUSION PROTEINS
#98Use of adiponectin for the diagnosis and/or treatment of presbycusis
#99Leptin agonist and methods of use
#100Albumin fusion proteins
#101Isolated antibodies against biologically active leptin-related peptides
#102METHODS, COMPOSITIONS AND TRANSGENIC MODELS RELATED TO THE INTERACTION OF T-CADHERIN AND ADIPONECTIN
#103USE OF LEPTIN FOR THE PREVENTION OF EXCESS BODY WEIGHT AND COMPOSITION CONTAINING LEPTIN
#104Site-specific chemical modification of proteins at their N-termini, enabling the formation of homogeneous adducts
#105Adiponectin and uses thereof
#106Modulators of body weight, corresponding nucleic acids and proteins
#107COMPOSITIONS AND METHODS FOR TREATING OBESITY AND RELATED METABOLIC DISORDERS
#108Compounds and their effects on feeding behaviour
#109Process For Preparing Serine-Rich Protein Employing Cysteine Synthase (CYSK) Gene
#110Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof
#111Y4 selective receptor agonists for therapeutic interventions
#112Amylin derivatives
#113OBG3 globular head and uses thereof
#114Albumin Fusion Proteins
#115Albumin Fusion Proteins
#116Method of reducing or inhibiting ObR signaling using a leptin antagonist consisting of SEQ id No: 2
#117ADMINISTRATION OF ADIPOCYTOKINE AND ADIPONECTIN FOR TREATING HEADACHE AND METHODS OF DIAGNOSING HEADACHE BY MEASURING ADIPONECTIN
#118SECRETED PROTEIN CCDC80 REGULATES ADIPOCYTE DIFFERENTIATION
#119Albumin fusion proteins
#120Compounds for Use in the Treatment of Obesity
#121NOVEL GENE AND USES THEREFOR
#122Albumin Fusion Proteins
#123Albumin fusion proteins comprising insulin polypeptides
#124Albumin Fusion Proteins
#125G-CSF-albumin fusion proteins
#126Use of Leptin for the Prevention of Excess Body Weight and Composition Containing Leptin
#127Albumin fusion proteins
#128Leptin-related peptides
#129Protein conjugates with a water-soluble biocompatible, biodegradable polymer
#130Nucleic acids encoding OBG3 polypeptides
#131Albumin fusion proteins
#132Albumin fusion proteins
#133Methods of increasing lean tissue mass using OB protein compositions
#134HUMAN LEPTIN-DERIVED POLYPEPTIDES AND USES THEREOF
#135GENES ASSOCIATED WITH OBESITY AND METHODS FOR USING THE SAME
#136Isolated antibodies against biologically active leptin-related peptides
#137Methods and materials relating to novel polypeptides and polynucleotides
#138Polypeptide variants
#139Rational Chemical Modification of Adiponectin Variants
#140Obesity-related genes
#141OB fusion protein compositions and methods
#142Adiponectin variants
#143GPCR-LIKE RETINOIC ACID-INDUCED GENE 1 PROTEIN AND NUCLEIC ACID
#144Globular adiponectin variants
#145Albumin fusion proteins
#146Homotrimeric extended OBG3 globular head and uses thereof
#147Compositions for blocking the inhibitory effect of human CRP on human leptin
#148OB protein-immunoglobulin chimeras
#149Albumin fusion proteins
#150Ligand of the protein "beacon"
#151Leptin antagonists
#152Protein chip for analyzing interaction between protein and substrate peptide thereof
#153Full-length human cdnas encoding potentially secreted proteins
#154Leptin antagonist
#155Isolated polypeptide comprising a leptin fragment
#156Proteins involved in the regulation of energy homeostasis
#157OBG3 Fragments Inhibiting The Conversion Of Active OBG3 Into Less Active OBG3 And Other Compositions For Treatment Of Metabolic Disorders
#158C1q family member proteins with altered immunogenicity
#159Lipin1 function
#160Leptin peptide antagonists
#161Polypeptide variants
#162NOVEL PEPTIDES CONFERRING ENVIRONMENTAL STRESS RESISTANCE AND FUSION PROTEINS INCLUDING SAID PEPTIDES
#163Albumin fusion proteins comprising GLP-1 polypeptides
#164Methods of increasing lean tissue mass using OB protein compositions
#165OB fusion protein compositions and methods
#166Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor
#167Methods for using the obese gene and its gene product to identify hematopoietic progenitor cells
#168Secreted protein
#169Leptin proteins
#170GSSP4 polynucleotides and polypeptides and uses thereof
#171Genes associated with obesity and methods for using the same
#172Nucleic acids encoding OBG3 globular head and uses thereof
#173Gene associated with regulation of energy balance, obesity and diabetes and uses therefor
#174Leptin-related peptides
#175Secreted proteins